Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-03

Clinical Trial Update: Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes [Phase 3]

View source ↗

Summary

Phase 3 trial update for Lymphoseek in identifying lymph nodes has completed in breast cancer and melanoma, with results posted in 2013. The sponsor Navidea Bio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lymphoseek (tilmanocept)

Snippet

Sponsor: Navidea Biopharmaceuticals | Conditions: Breast Cancer, Melanoma | Phase 3 | Status: COMPLETED | Results posted: 2013-06-03